Sequenom

Bringing the power of science to healthcare. Sequenom, Inc. (NASDAQ: SQNM) is committed to enabling healthier lives through the development of innovative products and services. We serve patients and physicians by providing early patient management information. What makes this vision a reality? Our deep commitment to "Quality of Science." For us, only the highest quality is acceptable. We accept nothing less in the science that supports every product and service we offer. From development to commercialization of innovative tests, "Quality of Science" is the common element in everything we do.
Company Growth (employees)
Type
Public
HQ
San Diego, US
Founded
1994
Size (employees)
434 (est)
Sequenom was founded in 1994 and is headquartered in San Diego, US

Sequenom Office Locations

Sequenom has offices in San Diego, Salt Lake City, New York, Philadelphia and in 17 other locations
San Diego, US
Kalamazoo, US
Tucson, US
Spokane, US
Lansing, US
Colorado Springs, US
Springfield, US
Nashville, US
Charleston, US
Atlanta, US
Miami, US
Worcester, US
Portland, US
Boston, US
Austin, US
Los Angeles, US
Fort Worth, US
Sacramento, US
Philadelphia, US
New York, US

Sequenom Metrics

Sequenom Summary

Market capitalization

$286.2 m

Closing share price

$2.4
Sequenom's current market capitalization is $286.2 m.

Sequenom Financials

Sequenom's revenue is $162.4 m in FY, 2013 which is a 7.2% increase from the previous period.
FY, 2013FY, 2014FY, 2015

Revenue

$162.4 m$151.6 m$128.3 m

Revenue growth, %

(6.7%)(15.4%)

Gross profit

$59.7 m$68.1 m$61.3 m

Operating expense total

$158.1 m$104.6 m$157.9 m

EBIT

($98.4 m)($13.7 m)($7.9 m)

Net Income

($107.4 m)$1 m($16.3 m)

Operating cash flow

($62.2 m)$1.7 m($13 m)

Sequenom Online Presence

Sequenom News

Sequenom Company Life

You may also be interested in